BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20260829T105921Z
UID:813a976e-68a3-4487-974a-7789f3a29e34
DTSTART:20250423T090000Z
DTEND:20250423T170000Z
DESCRIPTION:The Open Targets Platform is a comprehensive research tool that
  supports systematic identification and prioritisation of potential therap
 eutic drug targets.‌ By integrating publicly available datasets along wi
 th data generated by the Open Targets consortium\, the Platform builds and
  scores target-disease associations.Earlier this year\, the Platform was e
 xpanded through the inclusion of variant\, study\, and credible set inform
 ation. The Platform now includes comprehensive variant annotation and the 
 results of state-of-the-art large scale statistical analysis\, including f
 ine-mapping\, colocalisation\, and locus-to-gene assignment across all com
 plex and molecular traits. Drawing from the GWAS Catalog\, the eQTL Catalo
 gue\, FinnGen\, the UK Biobank Pharma Proteomics Project and more\, users 
 can browse over 2.6 million credible sets to build more robust therapeutic
  hypotheses.This webinar will provide an introduction to the capabilities 
 and use cases for the Open Targets Platform\, and demonstrate the impact o
 f the newly introduced data. These allow you to dig deeper into the GWAS e
 vidence for a target-disease association\, explore our analyses of GWAS an
 d molecular QTL studies\, and relevant annotation data.
LOCATION:\, 
SUMMARY:From variant to drug target: using the expanded Open Targets Platfo
 rm to explore the genetics of target discovery
URL;VALUE=URI:https://www.ebi.ac.uk/training/events/variant-drug-target-usi
 ng-expanded-open-targets-platform-explore-genetics-target-discovery
END:VEVENT
END:VCALENDAR